Health & Immunity Biotechnology (HI-Bio) operates as a clinical-stage biotechnology enterprise focused on discovering and developing targeted precision medicines for severe immune-mediated diseases, particularly nephrology and autoimmune conditions. The executive leadership team is spearheaded by seasoned biotech professionals dedicated to advancing clinical pipelines through rigorous scientific research and strategic corporate partnerships. Under executive guidance, the company coordinates clinical trial execution, regulatory submissions, and translational medicine programs designed to bring transformative therapies from laboratory discovery stages to clinical application for patients suffering from high-unmet-need immunological disorders.